QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2018    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文 作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L. 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma 期刊论文 JOURNAL OF THORACIC DISEASE, 2018, 卷号: 10, 期号: 1 作者:  Zhao, Mengnan;  Zhan, Cheng;  Li, Ming;  Yang, Xiaodong;  Yang, Xinyu 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05 Lung adenocarcinoma  epidermal growth factor receptor (EGFR)  v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)  human epidermal growth factor receptor 2 (HER2)  programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1)   The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity 期刊论文 CELL DEATH & DISEASE, 2018, 卷号: 9 作者:  Zhang, Bing;  Zhou, Wen-Jie;  Gu, Chun-Jie;  Wu, Ke;  Yang, Hui-Li 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites 期刊论文 BIOMATERIALS, 2018, 卷号: 158 作者:  Xu, Fan;  Zhong, Huihai;  Chang, Ya;  Li, Dongdong;  Jin, Hongyue 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 TRAIL  Gene delivery  Monensin  Poly-gamma-glutamic acid  Death receptor  Drug resistance   CD25 and TGF-beta blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer 期刊论文 JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 卷号: 16 作者:  Pu, Ning;  Zhao, Guochao;  Yin, Hanlin;  Li, Jian-ang;  Nuerxiati, Abulimiti 收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05 Pancreatic ductal adenocarcinoma  Immunotherapy  Integrated immune ratio  Regulatory T cell  Program death receptor-1